CLINICAL_TRIALS
ClinicalTrials.gov record update
VERSATIS - Efficacy and Safety of Lidocaine 5% Plasters (Versatis® 5%) in Child, Adolescents and Young Adults With Neuropathic Pains or Vasoocclusive Sickle Cell Crisis Pains
This page presents selected fields from the linked source record. It does not add a medical interpretation.
Record identity and dates
- Source
- ClinicalTrials.gov
- Source record ID
- NCT01314300
- Title field or adapter rule
- protocolSection.identificationModule.officialTitle
- Ingested At
- 2026-04-28T10:35:49.282094+00:00
- Published At
- 2014-10-30T00:00:00+00:00
- Record Updated At
- 2014-10-30
- Timestamp Basis
- source retrieval time was not retained by the feed adapter
- Date limitation
- source retrieval time was not retained by the feed adapter
Fields recorded by this source
- protocolSection.conditionsModule.conditions
["Neuropathic Pains", "Vasoocclusive Sickle Cell Crises Pains"]- protocolSection.statusModule.lastUpdatePostDateStruct.date
"2014-10-30"- protocolSection.identificationModule.nctId
"NCT01314300"- protocolSection.identificationModule.officialTitle
"VERSATIS - Efficacy and Safety of Lidocaine 5% Plasters (Versatis\u00ae 5%) in Child, Adolescents and Young Adults With Neuropathic Pains or Vasoocclusive Sickle Cell Crisis Pains"- protocolSection.statusModule.overallStatus
"COMPLETED"- protocolSection.designModule.phases
["PHASE2"]- protocolSection.statusModule.resultsFirstPostDateStruct.date
""
Study condition terms
Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.
This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.